Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. FDA names GS1 to manage medtech identifiers
Not-for-profit supply standards group GS1 will manage the FDA’s medical device Unique Device Identifier program.
2. NuVasive’s new European teammates come from Medtronic, DePuy
NuVasive adds 3 new faces to its European operations, taking 1 from Medtronic and 2 from Johnson & Johnson’s DePuy subsidiary.
1. FDA walks back Regenesis contraindication
FDA regulators agree to lift a contraindication on Regenesis Biomedical’s Provant Therapy system, no longer discouraging its use in patients with metallic implants in the area of treatment.